CompuVax Overview
- Year Founded
-
2013

- Status
-
Out of Business
- Latest Deal Type
-
Out of Business
CompuVax General Information
Description
Developer of a proprietary recombinant, self-assembling nanoparticle platform designed to create novel antibody therapeutics. The company's platform can engineer antibodies directly, employing similar computational and directed evolution methods, enabling users to get a unique tool to discover high-affinity antibodies.
Contact Information
Website
compuvax.comCorporate Office
- 1155 Camino del Mar
- Suite 502
- Del Mar, CA 92014
- United States
Corporate Office
- 1155 Camino del Mar
- Suite 502
- Del Mar, CA 92014
- United States
CompuVax Valuation & Funding
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
2. Out of Business | 13-Dec-2019 | Completed | Out of Business | |||
1. Early Stage VC (Series A1) | 10-Sep-2015 | Completed | Generating Revenue |
CompuVax Cap Table
Stock | # of Shares Authorized |
Par Value | Dividend Rate ($) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
---|---|---|---|---|---|---|---|---|
Series A1 |
CompuVax FAQs
-
When was CompuVax founded?
CompuVax was founded in 2013.
-
Where is CompuVax headquartered?
CompuVax is headquartered in Del Mar, CA.
-
What industry is CompuVax in?
CompuVax’s primary industry is Biotechnology.
-
Is CompuVax a private or public company?
CompuVax is a Private company.
-
What is CompuVax’s current revenue?
The current revenue for CompuVax is
. -
How much funding has CompuVax raised over time?
CompuVax has raised $1M.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »